NCT03353831 2025-04-06
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
AGO Research GmbH
Phase 3 Completed
AGO Research GmbH
ARCAGY/ GINECO GROUP
Grupo Español de Investigación en Cáncer de Ovario
Hoffmann-La Roche